Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.32%
1,100.57
-3.53
-0.32%
—1,104.101,103.921,108.751,097.16——
SIXC
Communications
SIXC
Communications
SIXC
+0.16%
605.15
+0.99
+0.16%
—604.16604.16610.19604.12——
SIXE
Energy
SIXE
Energy
SIXE
-0.22%
1,195.19
-2.62
-0.22%
—1,197.811,200.581,213.071,192.02——
SIXI
Industrials
SIXI
Industrials
SIXI
-0.03%
1,739.91
-0.50
-0.03%
—1,740.411,739.551,750.271,730.60——
SIXM
Financials
SIXM
Financials
SIXM
+0.65%
638.56
+4.12
+0.65%
—634.44633.13639.87633.01——
SIXR
Staples
SIXR
Staples
SIXR
-1.11%
831.57
-9.33
-1.11%
—840.90839.53841.73831.10——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
213.36
-1.77
-0.82%
—215.13215.13215.85213.24——
SIXT
Technology
SIXT
Technology
SIXT
+0.17%
3,234.18
+5.47
+0.17%
—3,228.713,225.623,235.433,198.95——
SIXU
Utilities
SIXU
Utilities
SIXU
-0.02%
935.65
-0.22
-0.02%
—935.87938.37942.00935.65——
SIXV
Health care
SIXV
Health care
SIXV
-0.54%
1,449.26
-7.86
-0.54%
—1,457.121,452.741,466.881,449.18——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,382.45
-17.39
-0.72%
—2,399.842,389.712,394.612,371.22——
HPX:FRA
Hisamitsu Pharmaceutical Co Inc
€31.40
+0.64%
(+0.20) 1D
Apr 27, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for HPX...
Open
€31.40
High
€31.40
Low
€31.40
Mkt. cap
454.75B
Avg. vol.
0.00
Volume
0.00
52-wk high
€35.60
52-wk low
€21.40
No. of employees
3K
News stories
From sources across the web
Profile
The Hisamitsu Pharmaceutical Co., Inc., headquartered in Tosu and Tokyo, is a Japanese multinational pharmaceutical corporation that develops and markets prescription and over-the-counter drug products, especially external pain relieving products such as the transdermal patch. Hisamitsu has specialised in transdermal drug delivery system technology since the introduction of its original line of patches in 1903. Hisamitsu's products under the Salonpas and Bye-Bye Fever brands are exported to over fifty countries. Hisamitsu also manufactures the Mohrus and Mohrus-Tape lines of external pain relief prescription products for the Japanese drug market. The company also manufactures internal medicines, eyedrops for general application, and the Lifecella Face Mask, a skincare product. Hisamitsu has developed the only over-the-counter transdermal patches approved by the U.S Food and Drug Administration. Wikipedia
About Hisamitsu Pharmaceutical Co Inc
CEO-
Employees2.8K
Founded1847
HeadquartersTosu, Saga, Japan
SectorPharmaceutical industry
Websiteglobal.hisamitsu
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
May 2025
Aug 2025
Nov 2025
Feb 2026
Revenue
34.66B
40.28B
39.57B
48.51B
Cost of goods sold
13.38B
15.47B
16.43B
21.62B
Cost of revenue
13.38B
15.47B
16.43B
21.62B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
17.92B
20.04B
18.66B
21.58B
Operating expense
17.92B
20.04B
18.66B
21.58B
Total operating expenses
31.30B
35.52B
35.09B
43.20B
Operating income
3.37B
4.76B
4.48B
5.31B
Other non operating income
137.00M
211.00M
190.00M
211.00M
EBT including unusual items
3.79B
6.24B
6.33B
7.29B
EBT excluding unusual items
3.78B
6.31B
6.54B
7.32B
Income tax expense
1.15B
1.65B
1.34B
-47.00M
Effective tax rate
30.44%
26.47%
-
-0.64%
Other operating expenses
-
-
-
-
Net income
2.56B
4.46B
4.87B
7.27B
Net profit margin
7.40%
11.07%
-
14.99%
Earnings per share
-
-
-
-
Interest and investment income
599.00M
1.18B
773.00M
1.09B
Interest expense
-2.00M
-8.00M
-5.00M
-6.00M
Net interest expenses
597.00M
1.17B
768.00M
1.09B
Depreciation and amortization charges
-
-
-
-
EBITDA
-
6.51B
6.06B
7.07B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer